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1. Introduction
  Type 2 diabetes (T2DM) and its long-term complications 
have become a medical and social burden in China[1]. T2DM 
often shows concealed progress in early stages and remains 
asymptomatically for near 10 years[2]. It is reported in a 
Chinese investigation that near half of people with T2DM are 
undiagnosed[1]. Several clinical trials have demonstrated 
that early detection of subjects with diabetes and at high 
risk is essential for prevention and treatment[3-5]. Till 
now, the most widely used screening test is fasting plasma 
glucose (FPG) in health check up in most part of China. 
Almost half diabetes patients with higher 2 h-postload 
plasm glucose (2 h-PG) are missed by FPG[1,6-8]. OGTT is the 
gold standard test for the diagnosis of diabetes according 
to WHO. But it is time-consuming and inconvenient, and 
not used routinely in clinical, especially in health check 
up of large population. In 2009, International Expert 
Committee defined glycated haemoglobin (HbA1c) cut point
曒6.5% as new criteria for the diagnosis of diabetes[8]. A 
Chinese investigation reported that HbA1c threshold of 6.3% 
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was highly specific for detecting undiagnosed diabetes in 
Chinese adults[9].
  This study applied HbA1c thresholds test for screening 
diabetes in health check up in Hainan Island, China. 
We assessed the validity of HbA1c曒6.3% as a screening 
threshold for undiagnosed diabetes, and the validity of 
combined HbA1c曒6.3% and/or FPG曒7.0 mmol/L. 
  
2. Materials and methods
2.1. Participants
  A total of 1 389 individuals (male 880, female 509), aged 
27-91 years, mean age (53.80±12.11) years, who had orally 
consent of detecting diabetes in health check up were 
recruited from May 2010 to August 2011 in Health Check-
up Center of our hospital in Hainan Island.
2.2. Physical examination
 All participants followed the instruction of physical 
examination. Data of medical history, age, height, weight, 
blood pressure [systolic blood pressure (SBP) and diastolic 
blood pressure (DBP)] were recorded. The body mass index 
(BMI) was calculated as weight (kg) divided by squared 
height (m2).
2.3. Exclusion criteria
  A total of 32 participants with medical history of diabetes 
or antihyperglycemia agents, 8 with hepatic or kidney 
disease, 7 with anemia, 5 with kidney malfunction or 
suspicious infection were excluded.
2.4. Biochemical index determination
  Venous blood samples of all participants were drawn 
from antecubital vein in the same morning after overnight 
10 hours fasting. FPG (glucose oxidase method) and HbA1c, 
hemoglobin, triglycerides (TG), total cholesterol (TC), high 
density lipoprotein cholesterol (HDL-C), and low density 
lipoprotein cholesterol (LDL-C), uric acid (UA) , alanine 
aminotransaminase (ALT), aspartate aminotransferase 
(AST), glutamyltranspeptidase (GGT) were measured by an 
automatic biochemistry analyzer (Siemens Dimension Rxl 
MAX). Both intra- and inter-assay coefficients of variation 
(CVs) were in 3%. HbA1c was measured by high-performance 
liquid chromatography D10 (Bio-Rad, USA) with a normal 
range of 4.0%-6.0%. The intra- and inter-assay CVs were 
曑2.3% and 曑3% for HbA1c at values 曑8.5%, respectively.
2.5. Oral glucose tolerance test (OGTT)
  Subjects with HbA1c>5.9% or FPG曒6.1 mmol/L underwent 
a 82.5 g-glucose (containing a molecule of water) OGTT in 
one week.
2.6.  Diagnostic criteria 
  Diabetes was defined according to the World Health 
Organization diagnostic Criteria in 1999, FPG曒7.0 mmol/L, 
OGTT 2 h-PG曒11.1 mmol/L, or both[10].
2.7. Statistical analysis
  All data were analyzed using SPSS, Windows version 16.0. 
The continuous variables were presented as means±SD, 
the skewed variables presented as medians (interquartile 
range).The categorical variables were presented as number 
(percentages, %). Clinical characteristics of the values 
were analyzed by t test, or Chi-square test, the skewed 
variables were analyzed by Wilcoxon test. The sensitivity 
and specificity values of FPG and HbA1c were determined 
by the receiver operating characteristic curve. P values less 
than 0.05 was considered as statistically significant for a two 
sided test.
3. Results
  The clinical characteristics of the participants were shown 
in Table 1.
  We found participants with HbA1c <6.0% had significant 
lower SBP, DBP, BMI, FPG, TG, LDL, UA, GGT and age 
(P<0.001), and higher HDL (P<0.001), lower TC, ALT (P<0.01) 
than those with HbA1c 曒6.0%. The percentage of male 
subjects with HbA1c曒6.0% was significantly higher than that 
of female (P<0.001) in our study. A total of 842 subjects had 
HbA1c<6.0%, in which 32 had isolated FPG曒6.1 mmol/L, and 
495 had HbA1c曒6.0%. A total of 527 subjects who had HbA1c
曒6.0% or FPG曒6.1 mmol/L underwent a 82.5 g-OGTT test, 
and 234 subjects were newly diagnosed as diabetes, with the 
incidence rate as 44.4% (234/527). Among those 234 subjects, 
123 (123/234, 52.6%) had FPG曒7.0 mmol/L, and 111 (111/234, 
47.4%) had isolated 2 h-PG 曒11.1 mmol/L. A total of 181 
subjects had HbA1c曒6.5% alone (181/234, 77.35%), and 215 
had HbA1c曒6.3% alone (215/234, 91.88%) in newly diagnosed 
diabetes by criterion of WHO 1999. The different influence of 
criteria for diabetes diagnosis in this cohort was showed in 
Table 2.
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4. Discussion
  This study was based on routine health check up. We used 
HbA1c test as a screening tool of diabetes in routine heath 
check up and grouped participates into one with HbA1c<6.0% 
and other with HbA1c 曒6.0% at high risk of diabetes[8]. The 
analysis of their clinical features showed that subjects with 
HbA1c<6.0% had significant decreased blood pressure, 
BMI, TC, TG, LDH, UA, age, ALT, GGT, and higher HDL. 
Elevated blood pressure, BMI, TC, TG, LDH, age, and lower 
HDL were risk factors of diabetes[8,9]. While higher UA, 
ALT, GGT in subjects with HbA1c曒6.0% are possibly related 
to increased HbA1c, but the reason is unknown. Previous 
studies[11,12] reported HbA1c was a significant risk factor for 
T2DM in people with FPG曒110 mg/dL or FPG曑100 mg/dL. 
Participants with HbA1c曒6.0% had more diabetes-related 
metabolic disorders[8]. In our investigation, the incidence of 
undiagnosed diabetes was 52.6% in routine heath check-
up by use of FPG only. We detected undiagnosed diabetes 
in subjects with HbA1曒6.0% or FPG曒6.1 mmol/L by OGTT 
test, and 47.4% diabetes patients were diagnosed with 
isolated 2 h-PG曒11.1 mmol/L in OGTT test. This indicated 
that nearly 50% of undiagnosed diabetes will be missed if 
only FPG test is used in routine heath check up. Several 
studies have shown that HbA1c is similar or superior to FPG 
in screening or diagnosis of diabetes compared with the 
oral glucose tolerance test[9,13,14]. Bao et al[9] reported that 
an HbA1c threshold of 6.3% was highly specific for detecting 
undiagnosed diabetes in Chinese adults. Our study showed 
HbA1c曒6.3%[9] alone was efficient than FPG曒7.0 mmol/L 
and HbA1c曒6.5% in detecting undiagnosed diabetes, and 
HbA1c was a practical and convenient test for screening 
diabetes than FPG did in routine heath check up. HbA1c曒
6.3% combined FPG曒7.0 mmol/L is optimal for detecting 
early diabetes without clinical symptoms or newly onset 
diabetes with a normal HbA1c in routine heath check up. Our 
result is consistent with previous reports[9, 15-17]. HbA1c曒
6.3% combined FPG曒7.0 mmol/L is effective on screening of 
early diabetes in routine health check-up, and can benefit 
future cost-effectiveness of diabetic treatment.
Table 1
Clinical characteristics of participants.
Characteristics Total(n=1 337) HbA1c<6.0%(n=842) HbA1c曒6.0%(n=495)
SBP 124.89依18.47 121.12依17.64 131.28依18.09**
DBP   77.38依11.54   75.85依11.20    79.96依11.65 **
BMI 24.76依3.24 24.19依3.15  25.69依3.16 **
FPG   5.63依1.58   5.09依0.58    6.53依2.20 **
TC   5.38依0.97   5.32依0.89   5.48依1.07 *
TG   1.66依1.34   1.49依1.04      1.94依1.71**
HDL   1.30依0.42   1.33依0.43    1.24依0.39 **
LDL   3.30依0.81   3.23依0.75    3.40依0.89 **
UA 334.05依87.16 306.83依88.56 342.69依83.25**
AST   27.00依10.38 26.91依9.95 27.15依11.07
ALT   33.13依15.76   32.07依14.73  34.93依17.22*
GGT  38.04依37.00  33.43依32.98       45.90依41.88 **
Age  53.80依12.11  49.14依10.41 57.67依12.75 **
Gender (m/f) 850/487 472(55.6%)/370(76.0%) 378(44.4%)/117(24.0%)**
Data are expressed as mean依SD or number (%).**P<0.001, *P<0.01 HbA1c <6.0% vs. HbA1c曒6.0%.  
Table 2
Positive and negative rate of different criteria for diabetes diagnosis based on the criterion of WHO 1999.
Different criteria for diagnosis diagnosis Positive rate Negative rate
HbA1C≥6.5 77.35% (181/234)              22.65%(53/234)
HbA1C≥6.3* 91.88%(215/234) 8.12%(19/234)
HbA1C≥6.3 or FPG≥7.0 96.58%(226/234)             3.42%(8/234)
HbA1C≥6.5 or FPG≥7.0 85.90%(201/234)  14.10%(33/234)
* Threshold recommended by Bao et al. Glycated haemoglobin A 1C for diagnosing diabetes in Chinese population: Cross sectional epidemioloy survey.
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